Publications by authors named "Alpesh Amin"

Claim this Profile
C
Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States.
Michele Wilson, Yoav Golan, Dianne Nguyen, Morteza Yazdani, Alpesh N Amin

Infect Dis Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administrative Harm.
Marisha Burden, Gopi Astik, Amy Lynn Teleron, Alpesh N Amin

Med Clin North Am· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Storytelling: How to Make Data Meaningful?
Moises Auron, Alpesh N Amin, Michelle N Brooks, Suchita Shah Sata

Med Clin North Am· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic microangiopathy multidisciplinary assessment team: demographics, final diagnosis, treatment, and outcomes.
Matthew Nguyen, Gayathri Dileep, Samir Patel, Fawaz Al Ammary, Minh-Ha Tran, Benjamin J Lee, Alpesh Amin

BMC Nephrol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review and Meta-analysis of the Effectiveness of Remdesivir to Treat SARS-CoV-2 in Hospitalized Patients: Have the Guidelines Evolved With the Evidence?
Michele Bartoletti, Essy Mozaffari, Alpesh N Amin, Yohei Doi, Paul Loubet

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States.
Michele Wilson, Yoav Golan, Dianne Nguyen, Morteza Yazdani, Alpesh N Amin

Infect Dis Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review.
Christoph Wanner, Ming-Hui Zhao, Alpesh N Amin, Luca De Nicola, Andrew J Sauer

Adv Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Digital Asthma Self-Management Program for Adults: A Randomized Clinical Trial.
Jordan Silberman, Siavash Sarlati, Bronwyn Harris, Hanson Lenyoun, Manpreet Kaur, Alpesh N Amin

JAMA Netw Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-Risk Assessment of Rivaroxaban in Older Patients With Nonvalvular Atrial Fibrillation or Venous Thromboembolism.
Paul P Dobesh, Albert A Volkl, Ákos Ferenc Pap, C V Damaraju, Bennett Levitan, Alpesh N Amin

Drugs Aging· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19.
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Mark Berry, Alpesh N Amin

Clin Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salary Equity Among Subspecialty Fellows: A Call to Action.
Solomon Liao, Alpesh N Amin, Steven Barczi, Christine Barron, Laura E Degnon

Am J Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: "Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients" [Clin Ther 2024;46:778-784].
Essy Mozaffari, Aastha Chandak, Andrew Ustianowski, Christina G Rivera, Neera Ahuja, Alpesh N Amin

Clin Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease and Heart Failure.
Natalie Kreitzer, Nancy M Albert, Alpesh N Amin, Craig J Beavers, Richard C Becker

Cardiorenal Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era.
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Mark Berry, Alpesh N Amin

Clin Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores.
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Andre C Kalil, Heng Jiang, Alpesh N Amin

Clin Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Vulnerable Patients Hospitalized for COVID-19 With Remdesivir: A Retrospective Comparative Effectiveness Study of Mortality in US Hospitals.
Essy Mozaffari, Aastha Chandak, Mark Berry, Paul E Sax, Paul Loubet, Alpesh N Amin

Clin Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Results of Implantable Loop Recorder for Detection of Atrial Fibrillation After Stroke: Reveal LINQ Registry.
Kazunori Toyoda, Kengo Kusano, Yasuyuki Iguchi, Takanori Ikeda, Itsuro Morishima, Alpesh N Amin

J Am Heart Assoc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients.
Essy Mozaffari, Aastha Chandak, Andrew Ustianowski, Christina G Rivera, Neera Ahuja, Alpesh N Amin

Clin Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay of Donor-Recipient Relationship and Donor Race in Living Liver Donation in the United States.
Abdula Al-Seraji, Simeon Adeyemo, Ahmet Gurakar, Riya Shah, Suphamai Bunnapradist, Alpesh N Amin

Clin Transplant· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection Fraction.
Freny Vaghaiwalla Mody, Ravi K Goyal, Mayank Ajmera, Keith L Davis, Alpesh N Amin

Drugs Real World Outcomes· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study.
Yoko Narasaki, Csaba P Kovesdy, Amy S You, Keiichi Sumida, Yamini Mallisetty, Alpesh N Amin

Lancet Reg Health Am· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stethoscope barriers narrative review; It's time for a strategy unfriendly to multi-drug resistant organisms (MDROs).
W Frank Peacock, Abhay Dhand, Nancy M Albert, Zainab Shahid, Alfred Luk, Alpesh N Amin

J Infect Public Health· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria® Workup of Pleural Effusion or Pleural Disease.

J Am Coll Radiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Inpatient Electronic Consultations During the COVID-19 Crisis and Its Sustainability Beyond the Pandemic: Quality Improvement Study.
Anna S Aledia, Amish A Dangodara, Aanya A Amin, Alpesh N Amin

J Med Internet Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.
Suzana Margareth Lobo, Gaétan Plantefève, Girish Nair, Adilson Joaquim Cavalcante, Nara Franzin de Moraes, Alpesh Amin

EClinicalMedicine· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis